share_log

中国生物科技服务(08037.HK)前三季度净亏损6597.6万港元

China Biotech Services (08037.HK) had a net loss of HK$65.976 million in the first three quarters

Gelonghui Finance ·  Nov 13, 2023 04:48

Gelonghui November 13th 丨China Biotech Services (08037HK) announced that in the nine months ended September 30, 2023, the Group recorded a turnover of approximately HK$201 million, a sharp decrease of about 84.27% over the previous year. The Group recorded a net loss attributable to company owners of approximately HK$65.976 million, net profit attributable to company owners of HK$160 million for the same period last year, and a basic and diluted loss of HK$0.068 per share.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment